Regentis Biomaterials Ltd. (RGNT)
NYSEAMERICAN: RGNT · Real-Time Price · USD
2.230
+0.240 (12.06%)
Aug 19, 2026, 4:00 PM EDT - Market closed
Regentis Biomaterials Market Cap
Regentis Biomaterials has a market cap or net worth of $11.55 million as of August 19, 2026.
Market Cap
11.55M
Enterprise Value
5.37M
1-Year Change
n/a
Ranking
Category
Stock Price
$2.23
ChartMarket Cap Chart
Since the IPO on December 4, 2025, Regentis Biomaterials's market cap has decreased from $39.44M to $11.55M, a decrease of -70.71%. That is a compound annual growth rate of -82.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 11.55M | -66.91% |
| Dec 31, 2025 | 34.91M | -11.48% |
| Dec 4, 2025 | 39.44M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nephros | 47.78M |
| Precision Optics Corporation | 47.01M |
| Milestone Scientific | 42.45M |
| Harvard Bioscience | 29.86M |
| Jin Medical International | 25.67M |
| Retractable Technologies | 20.96M |
| Bionano Genomics | 13.90M |
| Cuprina Holdings (Cayman) Limited | 7.83M |